In a nutshell This study investigated the safety of oxaliplatin to treat colorectal cancer in elderly patients. Researchers suggested that oxaliplatin treatment is associated with neuropathy (numbness of arms or legs) in these patients. Some background Colorectal cancer is one of the most common forms of cancer among the elderly....
Read MoreType(s) of chemotherapy-Single drug-Oxaliplatin (Eloxatin) Posts on Medivizor
Second-line treatment with panitimumab-FOLFIRI in metastatic colorectal cancer
In a nutshell This study reports the long term data on the use of panitimumab-FOLFIRI in metastatic colorectal cancer. Some background Many agents are now available for the treatment of metastatic colorectal cancer. FOLFIRI is a treatment method consisting of 5-flurouracil (slows or stops cell growth), leucovorin (Fusilev;...
Read MoreTowards guidelines to prevent colorectal cancer recurrence
This article presents results of recent studies concerning the interplay between the body's chemistry and behavioral factors that influence colorectal cancer (CRC) recurrence. Recent advances in CRC treatment have produced new and promising biological treatments. However, tumors sometimes have unique features that render many of these therapies...
Read MoreDo elderly or younger patients with stage II colon cancer benefit from adding Oxaliplatin to adjuvant chemotherapy?
In a nutshell This study tested whether chemotherapy after surgery ('adjuvant chemotherapy') including Oxaliplatin and FL (altogether called FOLFOX4) has any benefits in stage II and in elderly patients with colon cancer (CC). The main finding was that the addition of Oxaliplatin to FL as adjuvant...
Read More